"DMCR-Texas Cent for Drug Dev /ID# 164191

Houston, Texas 77081

0 studies enrolling now · 1 studies all time

What they study most

Psoriatic Arthritis

Studies at this site

• A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) — Completed